Skip to content

Evaluation of the Effectiveness of Surgical Treatment of Villo-nodular Synovitis of the Hip in Children

Evaluation of the Effectiveness of Surgical Treatment of Villo-nodular Synovitis of the Hip in Children in a Retrospective Case Series

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03507933
Acronym
SVN
Enrollment
6
Registered
2018-04-25
Start date
2018-01-30
Completion date
2018-06-30
Last updated
2018-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Synovitis

Keywords

villo-nodular synovitis, Hip, Surgery

Brief summary

Villo-nodular synovitis can affect the joints, bursae or tendon sheaths. This condition is rare, with 1.8 cases per million inhabitants. The hip is affected in 3.6 to 18.1% of cases. The age of predilection is between 30 and 50 years old and this condition is rarely described in children. Two articles report a case of villous-nodular synovitis of the child's hip. Surgical treatment by resection seems to be consensus but various adjuvant treatments are also proposed. A case of villous-nodular synovitis of the hip in children was treated without surgical intervention. The main objective of this study was to evaluate the efficacy of surgical treatment of villous nodular synovitis of the hip in children.

Detailed description

French multicentric cases serie

Interventions

None listed

Sponsors

Lille Catholic University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years

Inclusion criteria

* Children with histologically villo-nodular synovitis of the hip * Surgical procedures performed for the treatment of this synovitis

Exclusion criteria

* Degree of bone maturation and Risser test greater than 4 at the time of diagnosis * Parents opposing the use of their child's data / Patient opposing the use of his/her data

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in the range of motion of the hip in degreesbefore surgery and 4 months after surgeryEvaluation of extension / flexion / abduction / adduction / external rotation / internal rotation of the hip
Incidence of signal changes in the X-Ray4 months after surgery
Incidence of signal changes in the MRI4 months after surgery

Secondary

MeasureTime frameDescription
Change from baseline in the scale measure of patient's pain intensitybefore surgery and 4 months after surgery
Change from baseline in the physical activity evaluated by a questionnairebefore surgery and 4 months after surgeryyes /no questionnaire
Incidence of complications after surgery4 month after surgery
Number of additional treatments used in addition to surgery4 month after surgeryFrequency of adjuvant treatments

Countries

France

Contacts

Primary ContactAmélie Lansiaux, MD, PhD
lansiaux.amelie@ghicl.net+ 33 320225269
Backup ContactJustine Monvoisin
monvoisin.justine@ghicl.net+33 320223884

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026